Dr. Erin E. McGintee, MD

Dr. McGintee practices at ENT and Allergy Associates in Southampton, New York.

Dr. McGintee's NPI, 1295750412, was assigned on July 12, 2006. Dr. McGintee graduated from Renaissance School of Medicine at Stony Brook University in 2000. Dr. McGintee holds New York license 254231.

Dr. McGintee's primary practice is ENT and Allergy Associates, at 365 County Rd 39A, Southampton, NY 11968 in Suffolk County. The practice phone is (914) 333-5800.

Dr. McGintee's primary practice is ENT and Allergy Associates in Southampton, New York. Dr. McGintee is also affiliated with Stony Brook University Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. McGintee to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGintee practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. McGintee's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. McGintee is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. McGintee's licenses on file in 3 states: New York, New Jersey and Pennsylvania.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. McGintee treats.

CMS data shows 11,851 Medicare services from Dr. McGintee across 14 procedure codes in 2024, for 445 Medicare patients. Medicare paid $123,203 for them. Every service was in an office.

CMS counts 445 Medicare patients who saw Dr. McGintee in 2026. The largest group is 65 to 74, with 233 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McGintee's median patient age at 49, with 58% women.

In 2026, Dr. McGintee wrote 1,240 Medicare Part D claims for 292 patients. 50% of them were for generic drugs. CMS names the drug for 1,061 of them, across 24 drugs with 11 or more claims each, at $670,486 in total drug cost. In 2023, CMS named 881 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. McGintee for performance year 2026, reported as part of a group. Dr. McGintee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGintee as offering telehealth.

Dmand AI links 2 papers to Dr. McGintee, published from 2009 to 2024. Dr. McGintee's most frequent co-authors are Timothy Andrews, MD, Erin Michelle Banta and Ari Heffes-Doon, MD.

CMS Open Payments shows 564 general payments to Dr. McGintee from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,903.

Dmand AI lists 1 award for Dr. McGintee, most recently CMS Stage 1 EHR in 2013.

Dr. McGintee graduated from Renaissance School of Medicine at Stony Brook University in 2000.

Dr. McGintee is in network with 13 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.